Open access
Sep 2026
Phage-first treatment results in subpopulation-driven collateral sensitivity to beta-lactams in an extensively drug-resistant Pseudomonas aeruginosa
How specific beta-lactams can be prioritized and optimized in phage-antibiotic combinations to maximize the antibacterial activity is shown, providing mechanistic insights into phage-induced collateral sensitivity of beta-lactams.
Claire Han, Karishma Patel, Hao-Ran Gao et al.
· Antimicrobial Agents and Che... · 0 citations